Verizon is announcing a new price lock policy today, and the timing is probably no coincidence. The company is extending a ...

BioSciences announced the first patient has been dosed in the Phase 2 ASCEND study of PCRX-201 for the treatment of ...

RBC Capital keeps a Sector Perform rating on Sarepta (SRPT) after the company’s partner Roche (RHHBY) announced the European Medicines Agency ...